News Detail

Sangamo shares set to move to OTCQB as Nasdaq delists stock May 5

PUBT · 6d ago

Listen to the news

Sangamo shares set to move to OTCQB as Nasdaq delists stock May 5

Sangamo Therapeutics common stock is set to be delisted from Nasdaq Capital Market due to non-compliance with Nasdaq minimum bid price requirement.
Nasdaq trading is expected to be suspended at open May 5, 2026.
Shares are expected to begin trading on OTCQB Venture Market under symbol SGMO at open May 5, 2026.
Sangamo plans to request a Nasdaq hearing to appeal delisting determination, with no stay on the May 5 trading suspension.
Company is negotiating multiple potential business development transactions, with updates expected if definitive agreements are executed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sangamo Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604290805PRIMZONEFULLFEED9709252) on April 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.